Discovery of Lucensimycins A and B from Streptomyces lucensis MA7349 Using an Antisense Strategy

Organic Letters
2006.0

Abstract

Inhibition of protein synthesis is one of the validated and highly successful targets for inhibition of bacterial growth; this mechanism is a target of a large number of clinical drugs. Ribosomal protein S4, a primary protein, is a potential target for the discovery of antibacterial agents. We describe, using an antisense-sensitized rpsD Streptomyces aureus strain, the discovery and activity of lucensimycins A and B. [structure: see text].

Knowledge Graph

Similar Paper